Viewing Study NCT06462092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-01-22 @ 12:02 PM
Study NCT ID: NCT06462092
Status: RECRUITING
Last Update Posted: 2025-09-29
First Post: 2024-06-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Sponsor: Guangzhou Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leptomeningeal Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Her2- (Human Epidermal Growth Factor Receptor 2 Negative) View
None Breast cancer View
None Leptomeningeal Metastases View
None Sacituzumab Govitecan View
None Pemetrexed View
None Intrathecal chemotherapy View